Binding mechanism and biological effects of flavone DYRK1A inhibitors for the design of new antidiabetics
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Binding mechanism and biological effects of flavone DYRK1A inhibitors for the design of new antidiabetics ; volume:13 ; number:1 ; day:23 ; month:10 ; year:2023 ; pages:1-18 ; date:12.2023
Scientific reports ; 13, Heft 1 (23.10.2023), 1-18, 12.2023
- Urheber
-
Pustelny, Katarzyna
Grygier, Przemyslaw
Barzowska, Agata
Pucelik, Barbara
Matsuda, Alex
Mrowiec, Krzysztof
Slugocka, Emilia
Popowicz, Grzegorz M.
Dubin, Grzegorz
Czarna, Anna
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-44810-3
- URN
-
urn:nbn:de:101:1-2024020908033004231436
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pustelny, Katarzyna
- Grygier, Przemyslaw
- Barzowska, Agata
- Pucelik, Barbara
- Matsuda, Alex
- Mrowiec, Krzysztof
- Slugocka, Emilia
- Popowicz, Grzegorz M.
- Dubin, Grzegorz
- Czarna, Anna
- SpringerLink (Online service)
Ähnliche Objekte (12)
Structural mechanism of SGLT1 inhibitors
Synthesis, Biological Evaluation, and Binding Mode of a New Class of Oncogenic K‐Ras4b Inhibitors
Unmasking the biological function and regulatory mechanism of NOC2L: a novel inhibitor of histone acetyltransferase
Prediction of the binding mechanism of a selective DNA methyltransferase 3A inhibitor by molecular simulation
Biological functions of proteases and inhibitors
Characterization of the bipartite binding mechanism of Yos9
Mechanism of Action of Halofenate, A Platelet Inhibitor
Mechanism of antagonist ligand binding to REV-ERBα
Multistep mechanism of substrate binding determines chaperone activity of Hsp70
The mechanism of action of the adrenomedullin-binding antibody adrecizumab
Biophysical characterization of the mechanism of large GTP-binding proteins
Mechanism, autonomy and biological explanation
Structural mechanism of SGLT1 inhibitors
Synthesis, Biological Evaluation, and Binding Mode of a New Class of Oncogenic K‐Ras4b Inhibitors
Unmasking the biological function and regulatory mechanism of NOC2L: a novel inhibitor of histone acetyltransferase
Prediction of the binding mechanism of a selective DNA methyltransferase 3A inhibitor by molecular simulation
Biological functions of proteases and inhibitors
Characterization of the bipartite binding mechanism of Yos9
Mechanism of Action of Halofenate, A Platelet Inhibitor
Mechanism of antagonist ligand binding to REV-ERBα
Multistep mechanism of substrate binding determines chaperone activity of Hsp70
The mechanism of action of the adrenomedullin-binding antibody adrecizumab
Biophysical characterization of the mechanism of large GTP-binding proteins
Mechanism, autonomy and biological explanation
Structural mechanism of SGLT1 inhibitors
Synthesis, Biological Evaluation, and Binding Mode of a New Class of Oncogenic K‐Ras4b Inhibitors
Unmasking the biological function and regulatory mechanism of NOC2L: a novel inhibitor of histone acetyltransferase
Prediction of the binding mechanism of a selective DNA methyltransferase 3A inhibitor by molecular simulation
Biological functions of proteases and inhibitors
Characterization of the bipartite binding mechanism of Yos9
Mechanism of Action of Halofenate, A Platelet Inhibitor
Mechanism of antagonist ligand binding to REV-ERBα
Multistep mechanism of substrate binding determines chaperone activity of Hsp70
The mechanism of action of the adrenomedullin-binding antibody adrecizumab
Biophysical characterization of the mechanism of large GTP-binding proteins